Purchases and Sales Made in Q1 2024 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q1 2024. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
26.2KNew |
$13.1K - $22.5K
|
26.2K
$43.2K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
11.5KNew |
$5.74K - $9.87K
|
11.5K
$18.9K
|
|
|
May 15, 2024
Q1 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
2.4K+ 6.78% |
$1.2K - $2.06K
|
37.8K
$62.4K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1New |
$0.5 - $0.86
|
1
$1.65
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-4.4K- 61.15% |
$2.2K - $3.79K
|
2.8K
$4.62K
|
|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-16.3K- 28.97% |
$8.16K - $14K
|
40K
$66K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-68.1K- 96.06% |
$34.1K - $58.6K
|
2.8K
$4.62K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-68.1K- 96.06% |
$34.1K - $58.6K
|
2.8K
$4.62K
|